Monday, 24 October 2016

Image Guided Surgery Devices Market Advances with Improvement in Technology, Public Awareness; Market to Reach US$4.8 bn in 2022

A new Transparency Market Research report states that the global image guided surgery devices market, which was pegged at US$2.76 bn in 2013, is predicted to reach US$4.80 bn in 2022, expanding at a CAGR of 6.40% from 2014 to 2022. The title of the report is “Image Guided Surgery Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022.”

Get Sample Research Report with ToC:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2541
 
Image guided surgery is a term utilized for any type of surgical procedure wherein the surgeon utilizes tracked surgical instruments coupled with intraoperative and preoperative images for indirect guidance for the procedure. Image guided surgery systems utilize electromagnetic fields or cameras for capturing and relaying images of the anatomy of patients. Image guided surgery is used in a wide range of applications and is particularly utilized in surgery of the sinuses, where it aids in avoiding damage to the nervous system and the brain of the patient.

As per the report, the increasing demand for enhanced healthcare facilities and the rising healthcare expenditure globally are amongst the chief factors fuelling the market for image guided surgery devices. In addition, the rising popularity of IGS devices and the increasing initiatives taken by governments globally will also have a positive impact on the growth of the market. Furthermore, the developing markets hold a significant potential for the image guided surgery devices, hence propelling market development. The increasing count of partnerships and collaborations is a key trend seen in the market. On the other hand, the absence of skilled professionals and the soaring cost of installation of image guided surgery devices are amongst the major factors inhibiting the development of the market. In addition, the stringent regulatory needs and the lack of health insurance in emerging countries will also pose a negative impact on the growth of the market.

On the basis of device type, the report segments the market into ultrasound, computed tomography (CT) scanners, magnetic resonance imaging (MRI) machine, x-ray fluoroscopy machine, endoscope, single photon emission computed tomography (SPECT) equipment, and positron emission tomography (PET) machine. Amongst these, computed tomography (CT) scanners have the highest demand owing to the increasing applications of CT scanners in tumor detection and imaging of soft tissue structures. In addition¸ the turnaround time of these scanners is less, which is advantageous in critical and complicated surgeries. This segment stood at US$770 mn in 2013.

In terms of application, the report segments the market into orthopedic surgery, neurosurgery, oncology surgery, ear, nose, and throat surgery, and others. Amongst these, the segment of neurosurgery held the largest share in the market in 2013. The increasing accuracy of operating procedures is a key factor fuelling the growth of the neurosurgery segment. On the other hand, the demand for orthopedic image guided surgeries is also predicted to rise owing to the increasing aging population and the increasing occurrence of road accidents globally.

On the basis of geography, the report segments the market into Europe, North America, Latin America, Asia Pacific, the Middle East, and Rest of the World (RoW). Amongst these, North America led the market in 2013 and was trailed by Europe. The reasons for the superiority of both these regions include the increasing adoption rate of new technologies, the increasing healthcare expenditure, and the availability of trained healthcare professionals in these regions.

As per the report, the chief players dominant in the market are Toshiba Corporation, Siemens Healthcare, Koninklijke Philips N.V., St. Jude Medical, Inc., General Electric Company, Medtronic plc, Brainlab AG, and Varian Medical Systems, Inc., among others.

Browse Research Report on Global Image Guided Surgery Devices Market:
http://www.transparencymarketresearch.com/image-guided-surgery.html

Friday, 21 October 2016

Global Urgent Care Centers Market to Reach US$30.5 bn by 2020

The global urgent care centers (UCCs) market has several private companies operating urgent care chains in the market such as AFC/Doctors Express, FastMed Urgent Care, MD Now, Concentra Inc., CareSpot Express Healthcare LLC, MedExpress, MinuteClinic LLC, NextCare Urgent Care, Pateint First and U.S. HealthWorks Inc. Also, a large number of small market players are trying to enter and establish in the urgent care centers market. This has resulted in a highly fragmented market for UCCs industry with large number of urgent care chains accounting for less than 1% of the total market. Moreover, many private insurance firms are also becoming attracted towards the UCCs market. 


Cost Effective Visits and Faster Service Maintain UCCs on the Growth Front

Urgent care centers provide immediate care services to patients with minor injuries. The service time and quality of health care services in a UCC are better than that in an emergency department (ED). Additionally, the fee per visit paid by a patient, whether with health insurance or not, in UCCs is much lower than the fee paid in EDs. These advantages of UCCs over EDs are expected to increase the number of visits to UCCs, thus driving the growth of the global urgent care centers (UCCs) market.

Moreover, appointment flexibility provided by UCCs coupled with reduced waiting time has increased their popularity amongst patients. A surge in the population of insured people is also driving the urgent care centers market. The considerably low cost of treatment is attracting a large pool of insured patients. Furthermore, the growth of UCCs is backed by many private and public investors, thus increasing the pace of growth of urgent care centers exponentially.

Unavailability of Physicians Likely to Harm Visits to Urgent Care Centers

Continued shortages in the number of physicians are likely to limit the growth of the market and it will worsen in the next few years according to the Urgent Care Association of America (UCAOA) survey report. This can adversely affect the growth of the UCCs market. However, the effect of this restraint could be alleviated with physician assistants and nursing practitioners compensating this deficiency to some extent.

Another impediment to the growth of the UCCs market is the high initial cost required for the set-up of the urgent care centers. Apart from the establishment costs, a large number of patient visits per week are required to meet the huge operational costs of UCCs.

North America Leads With a Substantial Margin Owing to High Adoption Rate of UCCs

By geography, the global UGCs market is segmented into Europe, North America, Asia Pacific, and Rest of the World (RoW). North America, which was the leading segment by value in 2013, is anticipated to retain its leadership with a share of 73.6% in 2020. Europe, which stands second, is expected to lose its share by the end of 2020 due to lack of interest shown by private investors.

In terms of services, illness is the leading segment by revenue and is anticipated to remain the largest segment until 2020. However, screening services represent the fastest growing segment.

The information presented in this review is based on a Transparency Market Research report, titled, ‘Urgent Care Centers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020.’ 

Browse Research Report on Global Urgent Care Centers Market:
http://www.transparencymarketresearch.com/urgent-care-centers-market.html

Thursday, 20 October 2016

Process Analytical Technologies for Pharmaceuticals Market Global Trends 2023

Stringent regulations monitor pharmaceutical product manufacturing. Since pharmaceutical products directly relate to health and life of an individual, every step of pharmaceutical product manufacturing is under strict vigil and is considered a crucial affair. In a report, titled “Process Analytical Technologies for Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2023,” Transparency Market Research (TMR) studies the importance of process analytical technologies in analyzing, evaluating, and controlling the pharmaceutical product manufacturing. 


In terms of service, the process analytical technologies market can be segmented into calibration, database management system (DBMS), and consultancy. Based on application, coating, lyophilization, evaporation, compression, packaging, raw material selection, and others constitute the key segments in the global process analytical technologies market. 

Regionally, the market is spread across Asia Pacific, Europe, North America, and Rest of the World (RoW). Currently, North America and Europe enjoy the leading share in the market as these regions boast sophisticated healthcare infrastructure. However, TMR predicts growth witnessed by the market in Asia Pacific and across a few emerging economies in RoW to outpace that witnessed in developed regions. The accelerating investment in pharmaceutical infrastructure and technologies across developing economies will create lucrative opportunities for the process analytical technologies market. 

Spurred by aforementioned factors, TMR projects the process analytical technologies for pharmaceuticals market to grow at a robust pace between 2014 and 2020. Growth witnessed by the market will be particularly high in developing economies as they exhibit higher spending on technological advancements. Furthermore, the market is expected to gain from the higher investment in research and development of novel therapeutics. Besides this, stringent approval process for drugs and medical devices will aid the expansion of the process analytical technologies market. 

Following the recent technological advancements, the advent of several new medical devices is expected in the forthcoming years. The launch of these devices is likely to bolster opportunities for the process analytical technologies providers. With government and international agencies mandating various tests during pharmaceutical product manufacturing, the demand for process analytical technologies is expected to rise considerably during the forecast period. 

On the flip side, the lack of skilled professionals, threat of false results and malfunctions, and high cost of instruments will pose challenge to the process analytical technological market. It is critical to mitigate these concerns for key players to enjoy sustainable growth through the course of the forecast period. 

Some of the companies operating in the global process analytical technologies market are Honeywell, Tektronix, Inc., Agilent Technologies, Danaher Corporation, Thermo Fisher Scientific, Inc., Fluke Biomedical, and Carl Zeiss AG.

Browse Research Report on Global Process Analytical Technologies for Pharmaceuticals Market:
http://www.transparencymarketresearch.com/process-analytical-technologies-pharmaceuticals-market.html

Wednesday, 19 October 2016

Analysis of the Global Medication Management Market Trends and Forecast, 2016 - 2024

Global Medication Management Market: Overview 

The growing legal liabilities associated with medication errors have been reason enough for healthcare providers to invest in medication management systems. There is also a promising opportunity developing for medication management in homecare settings. While large multi-facility hospitals are the biggest users of medication management systems, smaller hospitals worldwide are warming up to the idea of streamlining their medication process as well. What works in the favor of the medication management market, however, is that implementation of such systems has become easier with the support of healthcare IT. The growing dependence of the aged—who comprised 11.7% of the global population in 2013—on healthcare providers to plan and dispense medication is further contributing to the revenue growth of the medication management market. 


Market data for medication management systems has been compiled based on sales and the corresponding revenue generated. Prices considered for the purpose of compiling data have are essentially averages taken from quotes provided by suppliers, distributors, and manufacturers. The report delves into the key segments of the medication management market by application, end use, and type. The size of key geographical markets has been derived via a summation of countries in each major region (North America, Asia Pacific, Europe, the Middle East and Africa, and Latin America). 

Global Medication Management Market: Trends and Drivers 

With more evidence emerging about the ability of medication management systems to make medication error-free, efficient, and more accessible to patients, a noticeably favorable outlook toward the solution is developing. Besides, the contribution of automated medication dispensing systems in establishing decentralized medication management systems is enticing more healthcare providers to invest in the latter. The factors listed above are collectively enabling the global medication management market to post progressively higher growth every year. 

Medication management systems are deployed at private healthcare centers, multi-facility and specialty hospitals, and in homecare settings. This necessitates the use of medication management systems of different sizes, features, and capabilities. For instance, medication management systems designed for personal use are primarily programmed to organize a weekly medication schedule, setting reminders, and organizing regular visits by healthcare professionals. 

The market is currently witnessing strong demand for the following types of medication management systems: infusion solutions, point-of-care verification, medication analytics, medication technologies, and ADE surveillance. However, since it is still early days for the medication management market, a few complications still exist with their operation and maintenance. 

Global Medication Management Market: Segmentation and Vendor Landscape 

To dive into the second and third levels of the global medication management market, the report shears it down on the basis of the following criteria: type of medication management services and service provider type. Service providers such as private healthcare providers, hospitals, and others are analyzed in the report. 

The report also profiles the leading companies in the medication management market to trace their recent developments and milestones. The annual revenues of these companies, where available, have been provided in the report. Companies that either find a mention or are extensively profiled in the report include: CareFusion, Inc., B.Braun Melsungen AG, Baxter International, Inc., and Hospira, Inc. 

Browse Research Report on Global Medication Management Market:
http://www.transparencymarketresearch.com/medication-management-market.html

Dental Lasers to Play Pivotal Role in Enabling Global Dental Equipment Market touch US$7.6 bn by 2018

Transparency Market Research, a global market intelligence firm, has recently published a new market research report made available on the company website. The research study, titled “Dental Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018,” presents a detailed overview of the global dental equipment market, including market drivers and barriers, product segmentation, major geographical segmentation, and the competitive landscape of the market.According to the research study, in 2011, the global dental equipment market was valued at US$5.5 bn and is estimated to reach a value of US$7.6 bn by 2018, exhibiting a 4.70% CAGR between 2012 and 2018.


Dental equipment refers to tools that are used by dental professionals while providing dental treatment to a patient. These tools assist the dental professionals in examining, restoring, removing teeth, and other dental treatments. These devices also help the dental professionals in manipulating tissues so as to get a proper visual access throughout the dental treatment. Several types of dental equipment find application in dental hospitals and clinics for dental ailments including gingival diseases and caries.

Technical advancements in treatment and diagnostic technologies, the growing global geriatric population, surging demand for cosmetic dentistry, increasing disposable incomes, and the booming dental tourism industry are some of the major factors that are expected to boost the demand for dental equipment throughout the forecast period globally. However, the high cost of advanced equipment, the growing refurbished dental equipment market, fluoridation, and taxes on medical devices are some of the factors hampering the growth of the global dental equipment market.

The global market for dental equipment has been segmented on the basis of type into hygiene maintenance devices, systems and parts, dental radiology equipment, laboratory machines, dental lasers, and other equipment. In 2011, the systems and parts segment led the overall market owing to the diverse application range of these products, followed by the dental radiology equipment segment. On the other hand, the dental lasers segment is expected to grow rapidly over the forecast period.

The global market for dental equipment has been divided on the basis of geography into Asia Pacific, Europe, North America, and Rest of the World. As per the study, North America leads the overall market for dental equipment. The rapid growth of this region can be attributed to the high prevalence of dental caries among the population. In 2011, the North America market was followed by Europe, which accounted for a share of 35% in the global dental equipment market in 2011. Asia Pacific is estimated to register a slow growth rate in the next few years.

Furthermore, the competitive landscape of the global market for dental equipment market has been elaborated in the last section of the research study. The analysis includes the company profile, contact information, inception details, products offered, financial overview, business policies, and recent developments if any. The prominent players operating in the global dental equipment market include Biolase Inc., GC Corporation, Planmeca Oy, CareStream Health, Dentsply International Inc., Ivoclar Vivadent AG, Sirona Dental Systems, Henry Schein Inc., Danaher Corporation, and A-dec Inc.

Browse Research Report on Dental Equipment Market:
http://www.transparencymarketresearch.com/dental-devices-market.html

Tuesday, 18 October 2016

Home Healthcare Software Product Market Global Industry Size and Share 2024

Global Home Healthcare Software Market: Overview

Home healthcare is a wide segment consisting of various software, products and services which are provided at patients’ home. The trend observed globally is the shift of treatment from hospitals to homes in order to save expenses and gain cost effectiveness. The convenience and cost effectiveness offered by the home healthcare services and treatments over hospital treatment are the driving forces for this market. In the home healthcare market third party service providers are witnessing huge demand for better treatment quality and trained professionals. Asian countries such as Japan, India and China show high demand for home healthcare, as they contain a growing aging population. North America is also showing constant growth in the home healthcare market as reimbursement is offered on specific devices and health policies in the U.S.

Get Research Report with ToC on Home Healthcare Software Market:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12188

Cost & convenience, increasing awareness, rising prevalence of diseases & the growing aging population, technical advancements in healthcare segment and rising incidence of chronic diseases globally are some driving forces for global home healthcare market. Some of the factors restraining the growth of the home healthcare device market include changing nature of reimbursement policies, limited coverage for home healthcare devices, changing technologies and regulatory obstacles for the new era devices. Players in the home healthcare market can seek opportunities in cost efficient devices through strategic aligning and telehealth patient monitoring

Global Home Healthcare Software Market: Segmentation

The home healthcare software market is segmented on the basis of type of equipment, type of service provided and region. On the basis of type of equipment, the home healthcare market is segmented into monitoring equipment, therapeutic equipments and mobility assist & other equipment. This monitoring equipment segment is further segmented into home diabetes care devices, home holter monitors, home pregnancy/fertility tests, heart rate meters, home - apnea & sleep monitors, home patient monitors and other home patient monitors. Home healthcare therapeutic equipment segment is further segmented into home respiratory therapy equipment (medical ventilators and accessories, medical nebulizer kits and devices, continuous positive airway pressure products and oxygen delivery systems), home IV equipment, home insulin delivery devices, home dialysis equipment, hearing aids market and other home therapeutic equipment. Mobility assist equipment segment is further segmented into wheelchairs and related devices, walking assist devices and home medical furniture.

Home healthcare services market is segment into respiratory therapy services, infusion therapy, unskilled home healthcare and rehabilitation service providers (speech therapy, occupational therapy and physical therapy). On the basis of region, the home healthcare software, product and service market is segmented into North America, Europe, Asia Pacific and rest of the world (RoW).

Global Home Healthcare Software Market: Competitive Dynamics

Some major players in the home healthcare software, product & service market are Abbott Laboratories, Air Liquid S.A., Amedisys Inc., American Homepatient Inc., Apria Healthcare Group inc., Baxter International Inc., Bayer Ag, B. Braun Melsungen Ag, Carefusion Corporation, Coloplast A/S, Convatec Inc., Covidien Plc., C.R. Bard Inc., Eli Lilly and Company, Fresenius SE & Co Kgaa, GE Healthcare, Gentiva Health Services Inc., Philips Healthcare, Invacare Corporation, Lincare Holdings Inc., Medtronic Inc., Novo Nordisk, Siemens Healthcare, Sunrise Medical Inc., and Teleflex Incorporated, among others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Browse Research Report on Global Home Healthcare Software - Product & Service Market:
http://www.transparencymarketresearch.com/home-healthcare-software-product-service-market.html

Monday, 17 October 2016

Global Resorbable Implants Market Segment and Industry Size 2016 to 2024

A man made medical device which supports, enhances or replaces the existing, damaged or missing biological structure, by implanting it into the human body is called as implants. There are several types of implants available in the market with a wide range of specialties. One of which is Resorbable implant. These implants have special and distinguished property. Such implants are biologically assimilated into the body slowly and is not required to be removed after a stipulated time. They have several dental, orthopedic and vascular applications. Resorbable implants are the prosthetic in nature and are used to regularize the physiological function in the human body. The worldwide increasing life expectancy and declining mortality rate have resulted in increased population of the age group above 60 years. Hence globally the geriatric population is growing at a faster rate than any other age group. The demand of such a population is fast, safe and effective treatment for their age related medical problems. Several applications of such implants into the orthopedic and dental field has also triggered the demand and usage owing to appreciable patient outcome. This has gripped the consideration of resorbable-implant companies to invest into such a market. Also key players are keenly interested in developing and commercializing the implants that are more cost effective and which will fulfill the geriatric patient demand.


The dental treatment including the usage of implants has a wide range of medical conditions like reconstruction of craniomaxillofacial bone due to trauma and facial prosthetic to correct the facial deformities, Mandibular fixation etc. The orthopedic treatment with the usage of resorbable implants includes Hand surgery, Bankart procedure, Trauma, Scaphoid fractures, Ankle ligament lesions.
Examples of resorbable implants are resorbable stent, resorbable mesh, resorbable band, resorbable scaffolds, and resorbable tethers. Resorbable Stents are usually used in cardiac and vascular indication whereas resorbable mesh are used in general surgeries for wound healing. Resorbable bands scaffolds and tethers have orthopedic applications.

The material most commonly used in resorbable implants are polyglycolic acid, polylactic acid, polydiaxonone, poly-L-lactic acid, poly-D-lactic acid, polycaprolactone, poly beta hydroxybutyrate. Polyglycolic acid and Polylactic acid are most popular amongst the orthopedic implants due to its unique mechanical and biocompatible property which is mandatory for its application. The upcoming materials used in resorbable implants are poly-L-lactic acid and poly-D-lactic acid. The L isomer is not only biologically inert but also biodegradable and biocompatible which helps to initiate the neocollagenesis process. As a result collagen builds up at the site of injection over the time and the poly-L-lactic acid microparticles is metabolized to carbon dioxide and water and expelled through respiratory system. These materials are usually used in the screws and plates used in orthopedic indications.

Several factors which are majorly driving the growth of resorbable implants market are growing concern for chronic diseases, rising geriatric population, growing disposable incomes and high level of healthcare .In addition, increasing areas of application mainly in medical and dental streams will contribute to the market growth. The pipeline and the future advancement in resorbable implants is anticipated to have a robust market growth. However time consuming approval procedures of implants by regulatory bodies, reimbursement issues and high cost of treatment would hamper the growth of resorbable-implants market.

The global resorbable implants market is segmented based on product type as Resorbable Stent, Resorbable Mesh, Resorbable Band, Resorbable Scaffolds, and Resorbable Tethers.

The global resorbable implant market is segmented based on material type as Polyglycolic acid, Polylactic acid, Polydiaxonone, Poly-L-Lactic acid, Poly-D-Lactic Acid, Polycaprolactone, Poly beta Hydroxybutyrate.

The global resorbable implants market is segmented based on application as Orthopedic Surgeries, dental Surgery, vascular Surgery and General Surgery.

The global resorbable implants market is segmented based on end user as Hospitals, Ambulatory Surgical Centers, and Specialty Clinics.

Depending on geographic region, resorbable implants market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

By resorbable implants type, stents and mesh are the choice of implants among the relatively limited resorbable implants that are approved in the market. The bands, scaffolds and tethers are popular amongst the orthopedists and dentists and holds noticeable share due to its easy availability and lower cost.

North America region holds the largest share of the global resorbable implant market, in terms of revenue due to the stronger health care infrastructure and considerable pool of the key manufacturers. Following North America Europe is the second largest resorbable implants market owing to technological advancement in the region. In addition, high disposable income and increase in geriatric population in developing countries like India and China, are expected to drive the growth resorbable implants market in Asia.

Key companies operational in resorbable implants market are Proxy Biomedical Ltd, KLS Martin LP., Bionx Implants Inc., Tornier, Inc., Degradable Solutions AG, Integra Life Sciences Corporation, Johnson & Johnson Services, Inc.,

Browse Research Report on Global Resorbable Implants Market:
http://www.transparencymarketresearch.com/resorbable-implants-market.html